| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/22/1994 | WO1994006426A1 Methods for identifying and using low/non-addictive opioid analgesics |
| 03/22/1994 | US5296616 Optically active fluorine-containing compound |
| 03/22/1994 | US5296606 O-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same |
| 03/22/1994 | US5296605 2,4-thiazolidinedione compounds |
| 03/22/1994 | US5296597 Antibiotics |
| 03/22/1994 | US5296596 Hexahydroazepine derivatives, a process for their preparation |
| 03/22/1994 | US5296591 Trifluoromethylketone derivatives, processes for preparation thereof and use thereof |
| 03/22/1994 | US5296589 Dissolving in nonreactive solvent, reacting with hydrogen, palladium chloride, hydrochloric acid in sealed vessel at elevated pressure, removing palladium chloride, neutralizing, separating product |
| 03/22/1994 | US5296514 Corneal treatment agents |
| 03/22/1994 | US5296509 Thioester enantiomeric compounds and their therapeutic uses |
| 03/22/1994 | US5296507 Treatment of cerbrovascular disorders |
| 03/22/1994 | US5296505 Reacting dithianepropenol with ethynyl-beta-ionol in presence of organomagnesium compound, hydrogenating triple bond, reducing diol with low-valency titanium |
| 03/22/1994 | US5296504 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 03/22/1994 | US5296503 Medicaments containing substituted 2-cyclohexene derivatives and their use for the control of candida infections |
| 03/22/1994 | US5296500 Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy |
| 03/22/1994 | US5296498 Guanidine compounds |
| 03/22/1994 | US5296496 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 03/22/1994 | US5296495 Thiazolylbenzofuran derivatives and pharmaceutical composition comprising the same |
| 03/22/1994 | US5296494 Pyrrolidine compounds having thromboxane A2 receptor antagonistic activity and thromboxane A2 synthase inhibiting activity |
| 03/22/1994 | US5296492 Certain chroman derivatives useful for treating symptoms caused by contraction of smooth muscles, circulatory diseases or epilepsy |
| 03/22/1994 | US5296491 Pyrazolo[4,3-c]pyridines and their use as serotonin reuptake inhibitors |
| 03/22/1994 | US5296490 Pharmaceutically useful pyrazolopyridines |
| 03/22/1994 | US5296486 Leukotriene biosynthesis inhibitors |
| 03/22/1994 | US5296482 (Benzocycloalkyl) alkylamines |
| 03/22/1994 | US5296481 Treatment process for promoting weight loss employing a substituted Δ5 |
| 03/22/1994 | US5296479 Treating physiological or drug-induced psychosis or dyskinesia |
| 03/22/1994 | US5296477 Aminoalkyl benzoxazine and benzthiazine compounds having a high 5-HT1A affinity |
| 03/22/1994 | US5296475 Methanediphosphonic acids and crown compounds for treatment of bone disorders or hypercalcemia |
| 03/22/1994 | US5296472 Methods for delipidation of skin and cerumen removal |
| 03/22/1994 | US5296471 Method for controlling o-desulfation of heparin and compositions produced thereby |
| 03/22/1994 | US5296469 Diosmin heptakis hydrogensulfate aluminum complex |
| 03/22/1994 | US5296463 Compositions and methods for improving cold tolerance in animals and humans |
| 03/22/1994 | US5296246 Active amino acid Ca, beverages containing same, and process for their production |
| 03/22/1994 | US5296243 Including in feed sugars, sugar alcohols, amino acids or amides to produce lectins which attach to agarose in neutral buffer, dissociate after addition of methyl glucoside |
| 03/22/1994 | US5296242 Aqueous solution and the use thereof |
| 03/22/1994 | US5296241 Basic suspension of finely powdered acetaminophen and antacid |
| 03/22/1994 | US5296237 Water-soluble pharmaceutical metallocene-complex composition |
| 03/22/1994 | US5296236 Controlled release therapeutic system for a liquid pharmaceutical formulations |
| 03/22/1994 | US5296235 Plaster preparation |
| 03/22/1994 | US5296231 Producing liposome encapsulated DNA repair enzyme |
| 03/22/1994 | US5296225 Topically applying preparation containing capsaicin to skin overlying trigeminal and cervical nerves |
| 03/22/1994 | US5296215 Containing sodium lauryl sulfate surfactant and alkyl glycoside |
| 03/22/1994 | CA2145207A1 Methods for identifying and using low/non-addictive opioid analgesics |
| 03/22/1994 | CA1327977C Method of preparing 1 .alpha.-hydroxyvitamin d and 1 .alpha.-hydroxy-previtamin d compounds, and adduct of a previtamin d or tachysterol compound with a suitable dienophile |
| 03/22/1994 | CA1327971C Benzopyran compound and its pharmaceutical use |
| 03/22/1994 | CA1327970C Isolation of castanospermine and its use as an antidiabetic agent |
| 03/22/1994 | CA1327969C Substituted amine derivatives, their production and use |
| 03/22/1994 | CA1327936C Phospholipase a_ inhibiting compositions and their use |
| 03/19/1994 | CA2106443A1 Thiomarinol derivatives, and processes for their preparation |
| 03/19/1994 | CA2106248A1 Preparation of beta-methyl carbapenem intermediates |
| 03/18/1994 | EP0575613A4 Pharmaceutical preparation of antistress, stress-preventive and nootropic action. |
| 03/18/1994 | EP0573565A4 Opiate receptor antagonist modulates hyperkinetic movement disorder. |
| 03/18/1994 | EP0559804A4 Diaper rash treatment. |
| 03/17/1994 | WO1994005813A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 03/17/1994 | WO1994005804A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | WO1994005777A1 Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway |
| 03/17/1994 | WO1994005694A1 Platelet aggregation inhibitors |
| 03/17/1994 | WO1994005693A1 New aminoacid derivates, process for producing the same and pharmaceutical compositions containing these compounds |
| 03/17/1994 | WO1994005691A1 Cd27 ligand |
| 03/17/1994 | WO1994005687A1 Antiviral pyrimidine nucleosides |
| 03/17/1994 | WO1994005683A1 Rokitamycin monohydrate crystal and process for producing the same |
| 03/17/1994 | WO1994005677A1 Phosphono substituted tetrazole derivatives |
| 03/17/1994 | WO1994005674A1 Tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds |
| 03/17/1994 | WO1994005671A1 Fullerene derivatives, method of synthesizing them and their use |
| 03/17/1994 | WO1994005669A1 Cationic-2-heteroarylphenyl-carbapenem antibacterial agents |
| 03/17/1994 | WO1994005667A1 Carbapenem derivatives and processes for preparing the same |
| 03/17/1994 | WO1994005666A1 Condensed carbapenem derivatives |
| 03/17/1994 | WO1994005663A1 Novel isoindolinone derivative, its preparation and pharmaceutical compositions containing same |
| 03/17/1994 | WO1994005661A1 Pyridopyrimidinone antianginal agents |
| 03/17/1994 | WO1994005660A1 Quinuclidine derivatives as squalene synthase inhibitors |
| 03/17/1994 | WO1994005659A1 Substituted thiazolidinedione derivatives |
| 03/17/1994 | WO1994005655A1 Antipsychotic quinoline derivatives of benzodioxanmethylamine |
| 03/17/1994 | WO1994005654A1 Heteroaryl compounds used as pharmaceuticals |
| 03/17/1994 | WO1994005652A1 4,5-dicyanoimidazole derivatives and pesticidal compositions containing them |
| 03/17/1994 | WO1994005649A1 4-hydroxy coumarin derivatives with antibacterial activity |
| 03/17/1994 | WO1994005648A1 Diaryl piperazinoacetamide compounds as antimuscarinic agents |
| 03/17/1994 | WO1994005646A1 Optically active carboxamide derivative |
| 03/17/1994 | WO1994005639A1 Sulfonamide inhibitors of hiv-aspartyl protease |
| 03/17/1994 | WO1994005635A1 Anti-viral sulfur-analogues of 1,5-dideoxy-1,5-imino-d-glucitol (deoxynojirimycin) |
| 03/17/1994 | WO1994005634A1 Benzo-fused lactams promote release of growth hormone |
| 03/17/1994 | WO1994005632A1 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use |
| 03/17/1994 | WO1994005631A1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs |
| 03/17/1994 | WO1994005630A1 1α,24(S)-DIHYDROXY VITAMIN D2, ITS FORMATION AND USE |
| 03/17/1994 | WO1994005531A1 Crank mechanism for a windscreen wiper drive of a motor vehicle |
| 03/17/1994 | WO1994005335A1 New organic contrast agent analog and method of making same |
| 03/17/1994 | WO1994005333A1 Oligonucleotide modulation of cell adhesion |
| 03/17/1994 | WO1994005330A1 Nasal spray products |
| 03/17/1994 | WO1994005319A1 Brain function ameliorant composition, learning capacity enhancer, mnemonic agent, dementia preventive, dementia curative, or functional food with brain function ameliorant effect |
| 03/17/1994 | WO1994005315A1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 03/17/1994 | WO1994005305A1 Digitalis-like compounds |
| 03/17/1994 | WO1994005302A1 Dermatitis treatment compositions containing sulphur, salicylic acid and a sulphydryl group releasing agent |
| 03/17/1994 | WO1994005299A1 Medicinal composition |
| 03/17/1994 | WO1994005297A1 Drugs containing diphosphonic acids and salts thereof |
| 03/17/1994 | WO1994005296A2 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 03/17/1994 | WO1994005295A1 Transdermal therapeutic system with pentylene tetrazol as active substance |
| 03/17/1994 | WO1994005294A1 Gastrointestinal formulations containing dimethylsulfone and allopurinol or oxypurinol |
| 03/17/1994 | WO1994005293A1 Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol |
| 03/17/1994 | WO1994005292A1 Gastrointestinal treatment compositions containing allopurinol or oxypurinol and a sulphydryl group releasing agent |
| 03/17/1994 | WO1994005291A1 Skin cancer treatment compositions containing dimethyl sulphone and oxypurinol or allopurinol |
| 03/17/1994 | WO1994005290A1 Platelet aggregation inhibitor |